Medtronic Infuse®-Off-Use Side Effects
Medtronic Infuse Bone Graft Lawsuit Information In 2002, the FDA granted Medtronic approval for its Infuse Bone Graft, a man made bone growth product for limited use in the lumbar spine region.
Despite this limited scope of approval, Medtronic, Inc., allegedly, promoted off-label uses of the Infuse bone graft including surgeries in the cervical spine, the thoracic spine, and also lateral and posterior approach of the lumbar spine.
Such off-label uses of the Medtronic Infuse Bone Graft have been associated with the following injuries:
- Severe swelling of your neck or throat
- Excess bone growth in the spine
- Chronic and severe pain in your legs or arms (inflammatory reaction)
- Male infertility
- Pancreatic, prostate or breast cancer
- Nerve damage
Peterson & Associates, P.C. fights hard to make sure medical device companies take responsibility for the pain and suffering they cause. Get immediate legal assistance by calling us.